Transition from Clinical Trials into RWE in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylarthritis

Introduction

Transition from Clinical Trials into RWE in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylarthritis

Objectives

Communicate Baricitinib and Ixekizumab value proposition in a speaker program setting in order to communicate what the product may mean to people living with Rheumatoid Arthritis Psoriatic Arthritis and Ankylosing Spondylarthritis diseases

This Course For :

Physician ( Internal Medicine , Rheumatology )
Resident / Fellow ( Internal Medicine , Rheumatology )
Clinical Pharmacy
Pharmacy

Speaker

Provided by :

Price

Course Fee

FREE

FREE
See Registration Policies, Cancellations & Refunds

Contact Information

Organization : Virtual Medical Academy
Phone : 920008161
Email : [email protected]

  • 16 Jul 2025    To    16 Jul 2025
  • 09:00 PM  To  10:30 PM
  • Certificate Available
  • Online
  • 58
  Add to Calendar 07/16/2025 09:00 PM 07/16/2025 10:30 PM Asia/ Riyadh Transition from Clinical Trials into RWE in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylarthritis Transition from Clinical Trials into RWE in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylarthritis https://medicalacademy.org/portal/event/view/2415
Transition from Clinical Trials into RWE in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylarthritis